Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R115777 in Advanced Urothelial Tract Transitional Cell Carcinoma
NCT00006376Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Mar 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in urothelial carcinoma (UC), sponsored by Moffitt Cancer Center. Started Mar 2000; status: completed.
02
Drugs
tipifarnib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00006376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006376.